British Sarcoma Group

Executive Office 35 Sandford Avenue Church Stretton Shropshire SY6 6BH Telephone 01694 722123

Trial Name	Axi-STS
Description	Axitinib in patients with advanced angiosarcoma and other soft tissue sarcomas: a phase II open-label parallel-group (non-randomised) study
Reference	ISRCTN 60791336 NCRN portfolio
Status / Sites	Open Aberdeen, Edinburgh, Clatterbirdge, Bristol, Leeds, Marsden (London and Sutton), UCLH, Manchester, Nottingham, Oxford, Sheffield, Southampton
UK Chief Investigator Contact	Prof Penella Woll, Sheffield

You are viewing the text version of this site.

To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.

Need help? check the requirements page.